Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU

Some physicians use dapsone as part of the standard treatment of severe COVID-19 patients entering the ICU, though some do not. To obtain an indication of whether dapsone is helping or not, we undertook a retrospective chart review of 29 consecutive ICU COVID-19 patients receiving dapsone and 30 not...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwar, Badar, Khattak, Asif, Kast, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779021/
https://www.ncbi.nlm.nih.gov/pubmed/36555204
http://dx.doi.org/10.3390/ijms232415563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779021/
https://www.ncbi.nlm.nih.gov/pubmed/36555204
http://dx.doi.org/10.3390/ijms232415563

Ejemplares similares